Effects of a collagen matrix containing basic fibroblast growth factor on wound contraction.
We evaluated the effectiveness of basic fibroblast growth factor (bFGF) in inhibiting wound contraction, both alone and in combination with collagen matrix, using a simulated in vivo delayed healing type model. We also studied the mechanisms involved in this inhibition in in vitro experiments using fibroblast populated collagen gels. As a result, we were able to demonstrate that both collagen matrix and bFGF significantly inhibited wound contraction; especially, bFGF acted in a dose-dependent fashion. Interestingly, their combination was much more effective than either collagen matrix or bFGF alone, a finding that was supported by the histopathological data. Wounds treated with collagen matrix, but not control wounds, showed horizontal rearrangement of collagen fibers in dermis as well as evidence of fibroblast proliferation, which was not observed in scar regions surrounded by normal dermis. Using fibroblast-populated collagen gel contraction as an in vitro model, we found that bFGF significantly inhibited contraction. Taking all these results together, it was concluded that collagen matrix is useful not only as a carrier of cytokines such as bFGF, but also for the quick closure of chronic wounds, thereby preventing contracture, which remains one of the most challenging problems in treating this type of wound. Application of bFGF-treated collagen matrix to chronic wounds such as decubitus, and diabetic and leg ulcers may prove to be highly beneficial in clinical practice.
Ono
I
I
Division of Plastic and Reconstructive Surgery, Department of Dermatology, Fukushima Medical University School of Medicine, Japan.
Tateshita
T
T
Inoue
M
M
D000818:Animals; D001672:Biocompatible Materials; D003094:Collagen; D005346:Fibroblast Growth Factors; D005347:Fibroblasts; D011817:Rabbits; D014945:Wound Healing
D001672:Biocompatible Materials; D005346:Fibroblast Growth Factors; D003094:Collagen